Chen Zongsheng, Liang Xianfa, Zhang Chunxiu, Wang Jinling, Chen Gaiping, Zhang Hong, Sun Zhongwu
Department of Neurology The First Affiliated Hospital of Anhui Medical University 218 Jixi Road 230022 Hefei Anhui China; Department of Neurology Tongling No. 4 People Hospital 98 Yangjiashan Road 244000 Tongling Anhui China.
Department of Neurology Tongling No. 4 People Hospital 98 Yangjiashan Road 244000 Tongling Anhui China.
Brain Behav. 2016 Mar 14;6(4):e00452. doi: 10.1002/brb3.452. eCollection 2016 Apr.
To date, the relationship between thyroid dysfunction and subcortical ischemic vascular disease (SIVD)-induced cognitive impairments still remains elusive.
Cognitive performances were examined in 215 participants, including 54 healthy participants, 52 SIVD patients with no dementia (SIVDND), 55 patients with mild cognitive impairment (SVMCI), and 54 patients with vascular dementia (VD). Serum thyroid-stimulating hormone (TSH), total triiodothyronine (TT3), free triiodothyronine (FT3), total thyroxine (TT4) and free thyroxine (FT4), thyroglobulin antibody (TGA), and antithyroid peroxidase antibody (TPO-Abs) were quantified by radioimmunoassay or ELISA.
A close correlation between thyroid status and cognitive dysfunction in SIVD was observed. Serum TT3 and FT3 levels decreased, whereas serum TSH level increased, with the decline in cognitive functions. Furthermore, TT3 levels showed a positive correlation, whereas TSH level showed a negative correlation, with the Mini-Mental State Examination (MMSE) scores. Our results suggested that thyroid function was associated with cognitive impairments induced by SIVD. Also, thyroid function and thyroid hormone level could be a risk factor in the development of SIVD. Serum TT3 and TSH levels might also be used as biomarkers for cognitive dysfunction.
These findings might contribute to a more accurate clinical diagnosis and differentiation among normal controls, SIVDND, SVMCI, and VD patients, in order to develop appropriate intervention approaches for SIVD therapeutic treatment.
迄今为止,甲状腺功能障碍与皮质下缺血性血管病(SIVD)所致认知障碍之间的关系仍不明确。
对215名参与者进行认知功能检查,其中包括54名健康参与者、52名无痴呆的SIVD患者(SIVDND)、55名轻度认知障碍患者(SVMCI)和54名血管性痴呆患者(VD)。采用放射免疫分析或酶联免疫吸附测定法对血清促甲状腺激素(TSH)、总三碘甲状腺原氨酸(TT3)、游离三碘甲状腺原氨酸(FT3)、总甲状腺素(TT4)、游离甲状腺素(FT4)、甲状腺球蛋白抗体(TGA)和抗甲状腺过氧化物酶抗体(TPO-Abs)进行定量分析。
观察到SIVD患者的甲状腺状态与认知功能障碍之间存在密切相关性。随着认知功能下降,血清TT3和FT3水平降低,而血清TSH水平升高。此外,TT3水平与简易精神状态检查表(MMSE)评分呈正相关,而TSH水平与MMSE评分呈负相关。我们的结果表明,甲状腺功能与SIVD所致认知障碍有关。此外,甲状腺功能和甲状腺激素水平可能是SIVD发生发展的一个危险因素。血清TT3和TSH水平也可能用作认知功能障碍的生物标志物。
这些发现可能有助于更准确地对正常对照、SIVDND、SVMCI和VD患者进行临床诊断和鉴别,以便为SIVD治疗开发合适的干预方法。